Literature DB >> 25222365

RETIRED: Osteoporosis in menopause.

Aliya Khan1, Michel Fortier2.   

Abstract

This document has been archived because it contains outdated information. It should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines.

Entities:  

Keywords:  anabolic; antiresorptive; bisphosphonates; bone forming agent; bone mineral density; bone turnover markers; calcitonin; diagnosis; dual energy x-ray absorptiometry; fragility fractures; hormone therapy; osteoporosis; prevention; selective estrogen receptor modulator; treatment; vertebral fractures

Mesh：

Year:  2014        PMID： 25222365     DOI： 10.1016/S1701-2163(15)30489-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN： 1701-2163


  17 in total

1.  An Interpretive Descriptive Approach to Understanding Osteoporosis Management from the Perspective of People at Risk of Fracturing.

Authors:  Christina Ziebart; Joy MacDermid; Rochelle Furtado; Mike Szekeres; Nina Suh; Aliya Khan
Journal:  Patient Prefer Adherence       Date:  2022-07-12       Impact factor: 2.314

2.  Osteoporosis treatment rate following hip fracture in a community hospital.

Authors:  Aliya A Khan; Hajar AbuAlrob; Farhan Tariq; Madiha Tauqir; Paul Zalzal; Iman M'Hiri; Moin Khan; Mark Ginty; Brad Weening
Journal:  Arch Osteoporos       Date:  2021-01-06       Impact factor: 2.617

3.  The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis.

Authors:  Fatemeh Abdi; Hamid Mobedi; Farhad Bayat; Nariman Mosaffa; Mahrokh Dolatian; Fahimeh Ramezani Tehrani
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

4.  Schisandrae Fructus Reduces Symptoms of 4-Vinylcyclohexene Diepoxide-Induced Ovarian Failure in Mice.

Authors:  Dasom Shin; Jinhee Ha; Seong Bin Hong; Geun-Hyung Kang; Deok-Sang Hwang; Hyunsu Bae
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-11       Impact factor: 2.629

5.  2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society.

Authors:  Yousef Al-Saleh; Riad Sulimani; Shaun Sabico; Hussein Raef; Mona Fouda; Fahad Alshahrani; Mohammad Al Shaker; Basma Al Wahabi; Mir Sadat-Ali; Hanan Al Rayes; Salwa Al Aidarous; Siham Saleh; Fakhr Al Ayoubi; Nasser M Al-Daghri
Journal:  Ann Saudi Med       Date:  2015 Jan-Feb       Impact factor: 1.526

6.  High Doses of Bupleurum falcatum Partially Prevents Estrogen Deficiency-Induced Bone Loss With Anti-osteoclastogenic Activity Due to Enhanced iNOS/NO Signaling.

Authors:  Mijung Yeom; Eun-Young Kim; Jae-Hyun Kim; Hyuk-Sang Jung; Youngjoo Sohn
Journal:  Front Pharmacol       Date:  2018-11-16       Impact factor: 5.810

7.  Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review.

Authors:  Michelle Gates; Jennifer Pillay; Guylène Thériault; Heather Limburg; Roland Grad; Scott Klarenbach; Christina Korownyk; Donna Reynolds; John J Riva; Brett D Thombs; Gregory A Kline; William D Leslie; Susan Courage; Ben Vandermeer; Robin Featherstone; Lisa Hartling
Journal:  Syst Rev       Date:  2019-08-23

8.  Biomechanical evaluation of axial-loading simulated experiment in wrist fractures: a finite element analysis.

Authors:  You-Liang Fan; Hai-Yun Xu; Ming-Yang Xia; Wen Zhang; Hui-Long Wen; Li-Bo Gao; Yan-Hui Pei
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

9.  Assessment of fecal Akkermansia muciniphila in patients with osteoporosis and osteopenia: a pilot study.

Authors:  Shahrbanoo Keshavarz Azizi Raftar; Zahra Hoseini Tavassol; Meysam Amiri; Hanieh-Sadat Ejtahed; Mehrangiz Zangeneh; Sedigheh Sadeghi; Fatemeh Ashrafian; Arian Kariman; Shohreh Khatami; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2021-01-23

10.  Taurine Activates BMP-2/Wnt3a-Mediated Osteoblast Differentiation and Mineralization via Akt and MAPK Signaling.

Authors:  Minsu Park; Hyeon Kyeong Choi; Jeung Hee An
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.